应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INO 伊诺维奥制药
已收盘 11-18 16:00:00 EST
4.08
-0.19
-4.45%
盘后
4.09
+0.01
+0.37%
19:46 EST
最高
4.24
最低
4.07
成交量
55.52万
今开
4.16
昨收
4.27
日振幅
3.99%
总市值
1.06亿
流通市值
9,726万
总股本
2,610万
成交额
228.32万
换手率
2.33%
流通股本
2,387万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
路透中文 · 11-18 15:15
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻
Reuters · 11-13
Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻
伊诺维奥制药盘中异动 快速跳水5.05%报5.26美元
市场透视 · 11-12
伊诺维奥制药盘中异动 快速跳水5.05%报5.26美元
Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻
Reuters · 11-06
Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻
伊诺维奥制药盘中异动 急速拉升5.23%
市场透视 · 11-04
伊诺维奥制药盘中异动 急速拉升5.23%
伊诺维奥制药盘中异动 股价大跌5.21%
市场透视 · 11-01
伊诺维奥制药盘中异动 股价大跌5.21%
伊诺维奥制药盘中异动 股价大涨5.55%
市场透视 · 10-12
伊诺维奥制药盘中异动 股价大涨5.55%
伊诺维奥制药盘中异动 股价大涨5.06%
市场透视 · 10-09
伊诺维奥制药盘中异动 股价大涨5.06%
伊诺维奥制药盘中异动 急速下跌5.14%报5.63美元
市场透视 · 09-25
伊诺维奥制药盘中异动 急速下跌5.14%报5.63美元
伊诺维奥制药盘中异动 早盘股价大跌5.09%
自选股智能写手 · 08-20
伊诺维奥制药盘中异动 早盘股价大跌5.09%
伊诺维奥制药2024财年第二财季实现净利润-32.24百万美元,同比增加9.26%
自选股智能写手 · 08-18
伊诺维奥制药2024财年第二财季实现净利润-32.24百万美元,同比增加9.26%
伊诺维奥制药盘中异动 早盘大幅下挫5.05%报7.90美元
自选股智能写手 · 08-13
伊诺维奥制药盘中异动 早盘大幅下挫5.05%报7.90美元
伊诺维奥制药盘中异动 早盘大幅跳水5.40%报8.24美元
自选股智能写手 · 08-09
伊诺维奥制药盘中异动 早盘大幅跳水5.40%报8.24美元
Inovio Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要
Reuters · 08-09
Inovio Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要
伊诺维奥制药盘中异动 股价大涨5.59%
自选股智能写手 · 08-08
伊诺维奥制药盘中异动 股价大涨5.59%
Inovio Pharmaceuticals Inc 预计每股亏损1.10美元 - 财报前瞻
Reuters · 08-07
Inovio Pharmaceuticals Inc 预计每股亏损1.10美元 - 财报前瞻
伊诺维奥制药盘中异动 股价大跌5.69%
自选股智能写手 · 08-02
伊诺维奥制药盘中异动 股价大跌5.69%
伊诺维奥制药盘中异动 早盘股价大跌5.07%报10.12美元
自选股智能写手 · 08-01
伊诺维奥制药盘中异动 早盘股价大跌5.07%报10.12美元
伊诺维奥制药盘中异动 股价大涨5.07%
自选股智能写手 · 07-26
伊诺维奥制药盘中异动 股价大涨5.07%
伊诺维奥制药盘中异动 临近午盘股价大涨5.07%报11.38美元
自选股智能写手 · 07-25
伊诺维奥制药盘中异动 临近午盘股价大涨5.07%报11.38美元
加载更多
公司概况
公司名称:
伊诺维奥制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Inovio Pharmaceuticals, Inc.最初成立于1983年6月29日,按照加利福尼亚州法律以生物科技实验公司之名注册。公司参与新一代疫苗(称为合成疫苗)的研发,该疫苗主要针对癌症和传染病。公司的SynCon技术使“宇宙号”疫苗能够提供对抗现有的或变化的病原体菌株的交叉防护,如流感病毒和HIV病毒。公司的电穿孔技术采用了简便的、受控的电脉冲来增加疫苗的细胞摄入。最初的人类实验数据表明这一方法能安全有效地增加基因表达和免疫应答。公司的临床计划包括宫颈非典型增生疫苗(治疗性)、禽流感疫苗(预防性)、前列腺癌疫苗(治疗性)、白血病疫苗(治疗性)、丙型肝炎病毒(HCV)疫苗和人类免疫缺陷病毒(HIV)疫苗。
发行价格:
--
{"stockData":{"symbol":"INO","market":"US","secType":"STK","nameCN":"伊诺维奥制药","latestPrice":4.075,"timestamp":1731963600000,"preClose":4.265,"halted":0,"volume":555194,"hourTrading":{"tag":"盘后","latestPrice":4.09,"preClose":4.075,"latestTime":"19:46 EST","volume":3314,"amount":13552.1721,"timestamp":1731977194493},"delay":0,"floatShares":23868637,"shares":26099991,"eps":-4.45336,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.19,"latestTime":"11-18 16:00:00 EST","open":4.16,"high":4.24,"low":4.07,"amount":2283240.7103818003,"amplitude":0.039859,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-4.45336,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":913093200000,"adjPreClose":4.265,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.25,"preClose":4.265,"latestTime":"09:29 EST","volume":4760,"amount":20227.09164,"timestamp":1731940195860},"postHourTrading":{"tag":"盘后","latestPrice":4.09,"preClose":4.075,"latestTime":"19:46 EST","volume":3314,"amount":13552.1721,"timestamp":1731977194493},"volumeRatio":0.966253,"impliedVol":0.8626,"impliedVolPercentile":0.4781},"requestUrl":"/m/hq/s/INO","defaultTab":"news","newsList":[{"id":"2484661939","title":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661939","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661939?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:15","pubTimestamp":1731914144,"startTime":"0","endTime":"0","summary":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals路透11月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Airbnb、Post Holdings 和 Syndax Pharmaceuticals。* Post Holdings Inc POST.N:摩根大通将目标价从125美元上调至135美元 * Syndax Pharmaceuticals Inc SNDX.O:杰富瑞将目标价从37美元上调至43美元 * Transmedics Group Inc TMDX.O:TD Cowen将目标价从175美元下调至120美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4S3MP0GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBI","BK1502","CAPR","IE00BZ08YR35.GBP","HK0000306701.USD","LU1481107354.HKD","YELP","TMDX","LU1439103000.SGD","IE00BZ08YT58.USD","KRRO","LU0051755006.USD","IE00B19Z9Z06.USD","PCOR","LU0543330483.HKD","LU0348788117.USD","HBBD.SI","LU1023057109.AUD","IE00BFMHRM44.USD","LU0228367735.SGD","LU0345776255.USD","LU0287142896.SGD","89988","LU0737861772.HKD","PGR","LU1983260115.SGD","09988","LU1048588211.SGD","BABA","EFXT","LU0516422440.USD","LU1688375341.USD","LU2355687059.USD","SNDX","LU0898667661.SGD","LU0543330566.HKD","LU0541502299.USD","TARS","INO","LU0293314216.USD","OVV","BK1521","ADSK","LU1196710864.SGD","BK4503","LU0251144936.SGD","LU1105468828.SGD","POST","ABNB","PLD"],"gpt_icon":1},{"id":"2483668098","title":"Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483668098","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483668098?lang=zh_cn&edition=full","pubTime":"2024-11-13 08:02","pubTimestamp":1731456170,"startTime":"0","endTime":"0","summary":" * Inovio Pharmaceuticals Inc 将于11月14日公布截至2024年9月30日的财报,预计该公司的季度收入将出现下降。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的38.8万美元下降73.1%,至10.45万美元。* LSEG 分析师对 Inovio 制药公司的平均预期是每股亏损 1.15 美元。* 华尔街对 Inovio Pharmaceuticals Inc 的 12 个月目标价中位数为 13.50 美元,高于其上次收盘价 5.15 美元。11月13日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO"],"gpt_icon":0},{"id":"2482275648","title":"伊诺维奥制药盘中异动 快速跳水5.05%报5.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482275648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482275648?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:09","pubTimestamp":1731348557,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时09分,伊诺维奥制药股票出现波动,股价快速跳水5.05%。截至发稿,该股报5.26美元/股,成交量19.0361万股,换手率0.73%,振幅5.60%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为0.71%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112020918971a5c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112020918971a5c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4583","BK4139"],"gpt_icon":0},{"id":"2481604777","title":"Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481604777","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481604777?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:54","pubTimestamp":1730901241,"startTime":"0","endTime":"0","summary":" * Inovio Pharmaceuticals Inc 预计将在11月7日公布截至2024年6月30日的业绩报告(估计),季度收入将出现下降。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从一年前的38.8万美元下降73.1%,至10.45万美元。* LSEG 分析师对 Inovio 制药公司的平均预期是每股亏损 1.15 美元。* 华尔街对 Inovio Pharmaceuticals Inc 的 12 个月目标价中位数为 13.50 美元,高于其上次收盘价 5.62 美元。11月6日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inovio Pharmaceuticals Inc 预计每股亏损1.15美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO"],"gpt_icon":0},{"id":"2480580685","title":"伊诺维奥制药盘中异动 急速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580685?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:22","pubTimestamp":1730733721,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时22分,伊诺维奥制药股票出现异动,股价急速拉升5.23%。截至发稿,该股报5.74美元/股,成交量3.9809万股,换手率0.15%,振幅4.50%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为0.17%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423220298e404ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423220298e404ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","INO","BK4583"],"gpt_icon":0},{"id":"2480579590","title":"伊诺维奥制药盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480579590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480579590?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:13","pubTimestamp":1730398394,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时13分,伊诺维奥制药股票出现波动,股价大幅跳水5.21%。截至发稿,该股报5.27美元/股,成交量19.434万股,换手率0.75%,振幅5.22%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为3.59%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102131598e3fc7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102131598e3fc7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","INO","BK4139","BK4583"],"gpt_icon":0},{"id":"2474014567","title":"伊诺维奥制药盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474014567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474014567?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:17","pubTimestamp":1728663458,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日00时17分,伊诺维奥制药股票出现异动,股价急速拉升5.55%。截至发稿,该股报5.71美元/股,成交量21.6279万股,换手率0.83%,振幅5.36%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为1.36%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012001739ab697817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012001739ab697817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4583","BK4139"],"gpt_icon":0},{"id":"2474402653","title":"伊诺维奥制药盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474402653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474402653?lang=zh_cn&edition=full","pubTime":"2024-10-09 02:39","pubTimestamp":1728412772,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日02时39分,伊诺维奥制药股票出现异动,股价快速上涨5.06%。截至发稿,该股报5.60美元/股,成交量23.0705万股,换手率0.89%,振幅4.88%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为0.49%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009023932a1df1701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009023932a1df1701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","INO","BK4139","BK4583"],"gpt_icon":0},{"id":"2470264672","title":"伊诺维奥制药盘中异动 急速下跌5.14%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470264672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470264672?lang=zh_cn&edition=full","pubTime":"2024-09-25 23:29","pubTimestamp":1727278178,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日23时29分,伊诺维奥制药股票出现异动,股价快速跳水5.14%。截至发稿,该股报5.63美元/股,成交量17.5834万股,换手率0.68%,振幅4.54%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为0.23%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925232939ab65ecb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925232939ab65ecb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4583","BK4139"],"gpt_icon":0},{"id":"2460099007","title":"伊诺维奥制药盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460099007","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460099007?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:27","pubTimestamp":1724164058,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时27分,伊诺维奥制药股票出现异动,股价快速下挫5.09%。截至发稿,该股报7.46美元/股,成交量11.421万股,换手率0.44%,振幅4.96%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为0.16%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202227389719952e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202227389719952e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","INO","BK4583"],"gpt_icon":0},{"id":"2460673618","title":"伊诺维奥制药2024财年第二财季实现净利润-32.24百万美元,同比增加9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460673618","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460673618?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:01","pubTimestamp":1723910516,"startTime":"0","endTime":"0","summary":"8月18日,伊诺维奥制药公布财报,公告显示公司2024财年第二财季净利润为-32.24百万美元,同比增加9.26%;其中营业收入为100762.00美元,同比减少55.41%,每股基本收益为-1.19美元。从资产负债表来看,伊诺维奥制药总负债37.06百万美元,其中短期债务2.32百万美元,资产负债比为0.04,流动比率为0.05。机构评级:截至2024年8月18日,当前有5家机构对伊诺维奥制药目标价做出预测,其中目标均价为17.70美元,其中最低目标价为8.00美元,最高目标价为33.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800031695a1649c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800031695a1649c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO"],"gpt_icon":0},{"id":"2459434901","title":"伊诺维奥制药盘中异动 早盘大幅下挫5.05%报7.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459434901","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459434901?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:35","pubTimestamp":1723556110,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时35分,伊诺维奥制药股票出现波动,股价大幅下跌5.05%。截至发稿,该股报7.90美元/股,成交量3.047万股,换手率0.12%,振幅3.43%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为0.46%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321351196826028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321351196826028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4583","INO"],"gpt_icon":0},{"id":"2458591344","title":"伊诺维奥制药盘中异动 早盘大幅跳水5.40%报8.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458591344","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458591344?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:56","pubTimestamp":1723211802,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时56分,伊诺维奥制药股票出现波动,股价大幅下跌5.40%。截至发稿,该股报8.24美元/股,成交量7.8222万股,换手率0.30%,振幅3.79%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为1.16%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809215642941ffbf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809215642941ffbf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","INO","BK4583"],"gpt_icon":0},{"id":"2458937636","title":"Inovio Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458937636","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458937636?lang=zh_cn&edition=full","pubTime":"2024-08-09 05:52","pubTimestamp":1723153927,"startTime":"0","endTime":"0","summary":" * Inovio Pharmaceuticals Inc 公布的截至6月底的季度调整后每股亏损1.19美元,高于去年同期的每股亏损1.56美元。六位分析师对该季度的平均预期是每股亏损 1.10 美元。华尔街预期为每股亏损 1.28 美元至-94 美分。* Inovio Pharmaceuticals Inc 公布的本季度每股收益为亏损 1.19 美元。* 该公司一季度亏损 3224 万美元。* Inovio Pharmaceuticals Inc 的股价本季度上涨了 6.3%,今年迄今为止上涨了 40.4%。华尔街对 Inovio Pharmaceuticals Inc 的 12 个月目标价中位数为 16.50 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inovio Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4139","BK4583"],"gpt_icon":0},{"id":"2457452513","title":"伊诺维奥制药盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457452513","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457452513?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:40","pubTimestamp":1723131633,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时40分,伊诺维奥制药股票出现异动,股价大幅拉升5.59%。截至发稿,该股报9.07美元/股,成交量11.6688万股,换手率0.45%,振幅6.29%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为3.23%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808234034aefdf34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808234034aefdf34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4583","BK4139"],"gpt_icon":0},{"id":"2457834363","title":"Inovio Pharmaceuticals Inc 预计每股亏损1.10美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457834363","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457834363?lang=zh_cn&edition=full","pubTime":"2024-08-07 09:56","pubTimestamp":1722995782,"startTime":"0","endTime":"0","summary":" * Inovio Pharmaceuticals Inc 将于8月8日公布截至2024年6月30日的财报,预计该公司的季度收入将出现下降。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于加利福尼亚州圣迭戈的公司的营收将从去年同期的22.597万美元降至12.15万美元,降幅为46.2%。* LSEG 分析师对 Inovio Pharmaceuticals Inc 的平均预期是每股亏损 100 美分。* 华尔街对 Inovio Pharmaceuticals Inc 的 12 个月目标价中位数为 16.50 美元,高于其最新收盘价 8.67 美元。8月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inovio Pharmaceuticals Inc 预计每股亏损1.10美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO"],"gpt_icon":0},{"id":"2456890522","title":"伊诺维奥制药盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456890522","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456890522?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605449,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分,伊诺维奥制药股票出现波动,股价快速跳水5.69%。截至发稿,该股报9.45美元/股,成交量6392股,换手率0.02%,振幅0.00%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为0.92%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213049aefcf802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213049aefcf802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","INO","BK4583","BK4139"],"gpt_icon":0},{"id":"2456843705","title":"伊诺维奥制药盘中异动 早盘股价大跌5.07%报10.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456843705","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456843705?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:13","pubTimestamp":1722525200,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时13分,伊诺维奥制药股票出现波动,股价大幅下跌5.07%。截至发稿,该股报10.12美元/股,成交量7.4728万股,换手率0.29%,振幅4.97%。伊诺维奥制药股票所在的生物技术行业中,整体涨幅为0.74%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231320af956478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231320af956478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4139","BK4583","BK4568"],"gpt_icon":0},{"id":"2454409533","title":"伊诺维奥制药盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454409533","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454409533?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:34","pubTimestamp":1722000866,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时34分,伊诺维奥制药股票出现波动,股价大幅上涨5.07%。截至发稿,该股报11.51美元/股,成交量1.8441万股,换手率0.07%,振幅2.74%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为0.06%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213426aefbb1b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213426aefbb1b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","INO","BK4583"],"gpt_icon":0},{"id":"2454806545","title":"伊诺维奥制药盘中异动 临近午盘股价大涨5.07%报11.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454806545","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454806545?lang=zh_cn&edition=full","pubTime":"2024-07-25 23:49","pubTimestamp":1721922584,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日23时49分,伊诺维奥制药股票出现波动,股价急速拉升5.07%。截至发稿,该股报11.38美元/股,成交量10.8028万股,换手率0.42%,振幅4.66%。伊诺维奥制药股票所在的生物技术行业中,整体跌幅为0.26%。伊诺维奥制药公司简介:Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司,致力于开发基于DNA的活性免疫疗法和疫苗,以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725234945af94219a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725234945af94219a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4583","BK4568","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inovio.com","stockEarnings":[{"period":"1week","weight":-0.2301},{"period":"1month","weight":-0.257},{"period":"3month","weight":-0.4553},{"period":"6month","weight":-0.6446},{"period":"1year","weight":-0.1331},{"period":"ytd","weight":-0.3031}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inovio Pharmaceuticals, Inc.最初成立于1983年6月29日,按照加利福尼亚州法律以生物科技实验公司之名注册。公司参与新一代疫苗(称为合成疫苗)的研发,该疫苗主要针对癌症和传染病。公司的SynCon技术使“宇宙号”疫苗能够提供对抗现有的或变化的病原体菌株的交叉防护,如流感病毒和HIV病毒。公司的电穿孔技术采用了简便的、受控的电脉冲来增加疫苗的细胞摄入。最初的人类实验数据表明这一方法能安全有效地增加基因表达和免疫应答。公司的临床计划包括宫颈非典型增生疫苗(治疗性)、禽流感疫苗(预防性)、前列腺癌疫苗(治疗性)、白血病疫苗(治疗性)、丙型肝炎病毒(HCV)疫苗和人类免疫缺陷病毒(HIV)疫苗。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.079806},{"month":2,"riseRate":0.2,"avgChangeRate":-0.050989},{"month":3,"riseRate":0.7,"avgChangeRate":0.154257},{"month":4,"riseRate":0.3,"avgChangeRate":-0.002831},{"month":5,"riseRate":0.6,"avgChangeRate":-0.028962},{"month":6,"riseRate":0.4,"avgChangeRate":0.04022},{"month":7,"riseRate":0.5,"avgChangeRate":-0.008365},{"month":8,"riseRate":0.5,"avgChangeRate":-0.055687},{"month":9,"riseRate":0.3,"avgChangeRate":-0.092385},{"month":10,"riseRate":0.3,"avgChangeRate":-0.041685},{"month":11,"riseRate":0.636364,"avgChangeRate":0.023773},{"month":12,"riseRate":0.2,"avgChangeRate":-0.073566}],"exchange":"NASDAQ","name":"伊诺维奥制药","nameEN":"Inovio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伊诺维奥制药(INO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伊诺维奥制药(INO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伊诺维奥制药,INO,伊诺维奥制药股票,伊诺维奥制药股票老虎,伊诺维奥制药股票老虎国际,伊诺维奥制药行情,伊诺维奥制药股票行情,伊诺维奥制药股价,伊诺维奥制药股市,伊诺维奥制药股票价格,伊诺维奥制药股票交易,伊诺维奥制药股票购买,伊诺维奥制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伊诺维奥制药(INO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伊诺维奥制药(INO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}